tiprankstipranks
Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
US Market

Supernus Pharmaceuticals (SUPN) Income Statement

Compare
499 Followers

Supernus Pharmaceuticals Income Statement

Last quarter (Q3 2024), Supernus Pharmaceuticals's total revenue was $175.69M, an increase of 14.17% from the same quarter last year. In Q3, Supernus Pharmaceuticals's net income was $38.50M. See Supernus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 607.52M$ 667.24M$ 579.77M$ 520.40M$ 392.75M
Gross Profit
$ 523.74M$ 580.02M$ 504.71M$ 467.94M$ 376.10M
Operating Expenses
$ 529.01M$ 534.40M$ 425.21M$ 292.34M$ 227.52M
Depreciation and Amortization
$ 84.86M$ 85.63M$ 32.59M$ 20.00M$ 10.22M
EBITDA
$ 90.04M$ 153.44M$ 129.19M$ 212.40M$ 180.42M
Operating Income
$ -5.27M$ 67.30M$ 86.03M$ 173.70M$ 148.57M
Other Income/Expenses
$ 8.04M$ 14.62M$ -12.85M$ -5.05M$ -1.08M
Pretax Income
$ 2.77M$ 60.74M$ 73.17M$ 168.65M$ 147.49M
Net Income
$ 1.32M$ 60.71M$ 53.42M$ 126.95M$ 113.06M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.02$ 1.13$ 1.01$ 2.41$ 2.16
Diluted EPS
$ 0.02$ 1.04$ 0.98$ 2.36$ 2.10
Weighted Average Shares Outstanding
54.54M 53.67M 53.10M 52.62M 52.41M
Weighted Average Shares Outstanding (Diluted)
55.51M 61.68M 54.36M 53.69M 53.82M
Currency in USD

Supernus Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis